A critical advance in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer protector protein is frequently lost in many types of malignancies, causing https://sb-bookmarking.com/story22067055/mini-antibodies-restore-tumor-suppressor-p53-a-new-approach-for-malignant-treatment